Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

No abstract is available for this paper.

• Publication year

  2007

• Venue

  ChemBioChem

• Publication date

  2007-11-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbic.200700427PMID 17939148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A small molecule targeting the multifactorial nature of Alzheimer's disease.

  2007cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Solution state characterization of amyloid beta-derived diffusible ligands.

  2006cited by this paper
• The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.

  2006cited by this paper
• The significance of neuroinflammation in understanding Alzheimer’s disease

  2006cited by this paper
• The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding

  2006cited by this paper
• Plaque-Derived Oxidative Stress Mediates Distorted Neurite Trajectories in the Alzheimer Mouse Model

  2006cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

  2006cited by this paper
• Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.

  2006cited by this paper
• Stoichiometric Inhibition of Amyloid β-Protein Aggregation with Peptides Containing Alternating α,α-Disubstituted Amino Acids

  2006cited by this paper
• PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Solution State Characterization of Amyloid β-Derived Diffusible Ligands

  2006cited by this paper
• The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression.

  2006cited by this paper
• Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid.

  2005cited by this paper
• Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation

  2005cited by this paper
• Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

  2005cited by this paper
• Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology*

  2005cited by this paper
• Modulatory effects of pH, Cu+2 and sheet breakers on aggregation of amyloid peptides.

  2005cited by this paper
• Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

  2005cited by this paper
• Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.

  2005cited by this paper
• Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

  2005cited by this paper
• Acetylcholinesterase-amyloid-beta-peptide interaction: effect of Congo Red and the role of the Wnt pathway.

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• How to study proteins by circular dichroism.

  2005cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants.

  2005cited by this paper
• Amyloid inhibitors and beta-sheet breakers.

  2005cited by this paper
• Beta-sheet breakers for Alzheimer's disease therapy.

  2004cited by this paper
• Structure and function of amyloid in Alzheimer's disease.

  2004cited by this paper
• Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

  2004cited by this paper
• β-Sheet Breakers for Alzheimers Disease Therapy

  2004cited by this paper
• Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization

  2004cited by this paper
• beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

  2003cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Kinetic Studies of Amyloid β-Protein Fibril Assembly

  2002cited by this paper
• Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease.

  2002cited by this paper
• Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization.

  2002cited by this paper
• Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

  2002cited by this paper
• Amyloid binding ligands as Alzheimer's disease therapies.

  2002cited by this paper
• Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry.

  2001cited by this paper
• Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.

  2001cited by this paper
• Amyloid-β oligomers: their production, toxicity and therapeutic inhibition

  2001cited by this paper
• Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

  2001cited by this paper
• Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology

  2001cited by this paper
• Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

  2001cited by this paper
• Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

  2001cited by this paper
• Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization.

  2000cited by this paper
• An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments

  2000cited by this paper
• An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.

  2000cited by this paper
• Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.

  2000cited by this paper
• Stereochemical specificity of Alzheimer's disease β-peptide assembly

  1999cited by this paper
• Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

  1999cited by this paper
• Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

  1999cited by this paper
• In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation

  1999cited by this paper
• Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.

  1999cited by this paper
• Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

  1999cited by this paper
• Watching amyloid fibrils grow by time-lapse atomic force microscopy.

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• Stereochemical specificity of Alzheimer's disease beta-peptide assembly.

  1999cited by this paper
• Quantifying Amyloid β-Peptide (Aβ) Aggregation Using the Congo Red-Aβ (CR–Aβ) Spectrophotometric Assay

  1999cited by this paper
• In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation.

  1999cited by this paper
• Structural and kinetic features of amyloid beta-protein fibrillogenesis.

  1998cited by this paper
• Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

  1997cited by this paper
• Acetonitrile-induced conformational transitions in poly-L-lysine.

  1997cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Congo red reverses amyloid β protein-induced cellular stress in astrocytes

  1997cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• The structure of amyloid fibrils by electron microscopy and X-ray diffraction.

  1997cited by this paper
• Observation of metastable Aβ amyloid protofibrils by atomic force microscopy

  1997cited by this paper
• Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

  1997cited by this paper
• Congo red reverses amyloid beta protein-induced cellular stress in astrocytes.

  1997cited by this paper
• On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

  1996cited by this paper
• Selective Inhibition of A Fibril Formation

  1996cited by this paper
• The Interaction of an Epidermal Growth Factor/Transforming Growth Factor α Tail Chimera with the Human Epidermal Growth Factor Receptor Reveals Unexpected Complexities*

  1996cited by this paper
• Thioflavine T interaction with amyloid β-sheet structures

  1995cited by this paper
• Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

  1994cited by this paper
• Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

  1993cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.

  1993cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

  1992cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

  1989cited by this paper

• Recent advances in small molecules for amyloid fibril inhibition: chemical strategies and molecular mechanistic insights from lysozyme and insulin models.

  2026cites this paper
• Hydrophilicity-Driven Modulation of Amyloid-β(1-40) Fibrillation by Engineered Nanomaterials.

  2025cites this paper
• Deciphering the full-length PrPC(23-231) receptor and characterizing the size/subphase-dependent impact of Aβ oligomers on the PrPC(23-231) receptor: insights from molecular dynamics simulations.

  2025cites this paper
• Rivastigmine Templates with Antioxidant Motifs—A Medicinal Chemist’s Toolbox Towards New Multipotent AD Drugs

  2025cites this paper
• New series of aromatic amides hybrids derivatives as anti-Alzheimer's drugs: Design, synthesis, biological activity and computational studies

  2025cites this paper
• Exploiting acylaminopyrazole scaffold for polypharmacology approach in Alzheimer's disease.

  2025cites this paper
• Inhibition of Human Amylin Aggregation: In Silico and In Vitro Studies

  2025cites this paper
• Phenolic fractions of Heliotropium Bacciferum inhibit human insulin aggregation and protect against amyloid-induced cytotoxicity: Structural and biophysical analysis.

  2025cites this paper
• Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer’s Disease

  2025cites this paper
• Pyranotacrines as prospective multi-target compounds against Alzheimer's disease.

  2025cites this paper
• Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships

  2025cites this paper
• New Multitarget Rivastigmine–Indole Hybrids as Potential Drug Candidates for Alzheimer’s Disease

  2024cites this paper
• Development of Aβ and anti-Aβ dynamics models for Alzheimer’s disease

  2024cites this paper
• Electrolyte-Gated Organic Field-Effect Transistor for Monitoring Amyloid Aggregation

  2024cites this paper
• Exploring the Aβ1-42 fibrillogenesis timeline by atomic force microscopy and surface enhanced Raman spectroscopy

  2024cites this paper
• Cold atmospheric pressure plasma assisted rapid assembly of peptide-based structures: a molecular scaffold to form supramolecular architectures

  2024cites this paper
• Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidates.

  2024cites this paper
• Examining the interaction and inhibition of lysozyme fibrillation by chelerythrine through multispectroscopic and imaging studies

  2024cites this paper
• Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies

  2024cites this paper
• Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases.

  2024cites this paper
• Characterizing Prion‐Like Protein Aggregation: Emerging Nanopore‐Based Approaches

  2024cites this paper
• Real-time analysis of the biomolecular interaction between gelsolin and Aβ1-42 monomer and its implication for Alzheimer's disease.

  2024cites this paper
• Supporting Information: Disrupting dimeric β -amyloid by electric fields

  2023cites this paper
• Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study

  2023cites this paper
• Synthesis and evaluation of butylphthalide-scutellarein hybrids as multifunctional agents for the treatment of Alzheimer's disease.

  2023cites this paper
• Origin of stronger binding of ionic pair (IP) inhibitor to Aβ42 than the equimolar neutral counterparts: synergy mechanism of IP in disrupting Aβ42 protofibril and inhibiting Aβ42 aggregation under two pH conditions.

  2023cites this paper
• Aggregation Dynamics Characteristics of Seven Different Aβ Oligomeric Isoforms-Dependence on the Interfacial Interaction.

  2023cites this paper
• Design of Self-Assembled Nanoparticles as a Potent Inhibitor and Fluorescent Probe for β-Amyloid Fibrillization.

  2023cites this paper
• Emodin derivatives as promising multi-aspect intervention agents for amyloid aggregation: molecular docking/dynamics simulation, bioactivities evaluation, and cytoprotection

  2023cites this paper
• Multifunctional agents against Alzheimer's disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions.

  2023cites this paper
• Danshensu inhibits Aβ aggregation and neurotoxicity as one of the main prominent features of Alzheimer's disease.

  2023cites this paper
• Aza-Residue Modulation of Cyclic d,l-α-Peptide Nanotube Assembly with Enhanced Anti-Amyloidogenic Activity.

  2023cites this paper
• Dictamnine derivatives as a novel family of dual inhibitors for cholinesterase and β-amyloid aggregation

  2023cites this paper
• The cellular model for Alzheimer's disease research: PC12 cells

  2023cites this paper
• A coumarin-based multifunctional chemosensor for Cu2+/Al3+ as an AD theranostic agent: Synthesis, X-ray single crystal analysis and activity study.

  2023cites this paper
• Disrupting Dimeric β-Amyloid by Electric Fields

  2023cites this paper
• A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs

  2023cites this paper
• Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors.

  2022cites this paper
• Eugenitol ameliorates memory impairments in 5XFAD mice by reducing Aβ plaques and neuroinflammation.

  2022cites this paper
• Aβ1-42 peptide toxicity on neuronal cells: A lipidomic study.

  2022cites this paper
• Engineering Nanointerfaces of Au25 Clusters for Chaperone-Mediated Peptide Amyloidosis.

  2022cites this paper
• Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure

  2022cites this paper
• Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer's disease.

  2022cites this paper
• Recent advances in the development of nitrogen-containing heterocyclic Anti-Alzheimer's agents.

  2022cites this paper
• Computational screening for new neuroprotective ingredients against Alzheimer's disease from bilberry by cheminformatics approaches

  2022cites this paper
• Inhibition of β-Amyloid Aggregation in Alzheimer’s Disease: The Key Role of (Pro)electrophilic Warheads

  2022cites this paper
• Targeting neuronal calcium channels and GSK3β for Alzheimer's disease with naturally-inspired Diels-Alder adducts.

  2022cites this paper
• Fluorescent aptasensor based on conformational switch–induced hybridization for facile detection of β-amyloid oligomers

  2022cites this paper
• Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease

  2022cites this paper
• Synthesis and Evaluation of Novel Ferulic Amide Derivatives and the Treatment of Alzheimer's Disease

  2022cites this paper
• Exploration of Isoquinoline Alkaloids as Potential Inhibitors against Human Islet Amyloid Polypeptide.

  2022cites this paper
• On the interaction of a donepezil-huprine hybrid with synthetic membrane models

  2022cites this paper
• Phthalimide‐(N‐alkylbenzylamine) cysteamide hybrids as multifunctional agents against Alzheimer’s disease: Design, synthesis, and biological evaluation

  2021cites this paper
• Multifunctional fluorescence sensor as a potential theranostic agent against Alzheimer's disease.

  2021cites this paper
• 2-(3-Hydroxybenzyl)benzo[d]isothiazol-3(2H)-one Mannich base derivatives as potential multifunctional anti-Alzheimer’s agents

  2021cites this paper
• Toward the equilibrium and kinetics of amyloid peptide self-assembly.

  2021cites this paper
• Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes

  2021cites this paper
• Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.

  2021cites this paper
• New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators

  2021cites this paper
• Sulfated polysaccharide ascophyllan prevents amyloid fibril formation of human insulin and inhibits amyloid-induced hemolysis and cytotoxicity in PC12 cells.

  2021cites this paper
• From Combinations to Single-Molecule Polypharmacology—Cromolyn-Ibuprofen Conjugates for Alzheimer’s Disease

  2021cites this paper
• Nanostructure, Self-Assembly, Mechanical Properties, and Antioxidant Activity of a Lupin-Derived Peptide Hydrogel

  2021cites this paper
• (±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.

  2021cites this paper
• Multi‐Targeting Tacrine Conjugates with Cholinesterase and Amyloid‐Beta Inhibitory Activities: New Anti‐Alzheimer's Agents

  2021cites this paper
• Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease.

  2021cites this paper
• Single Molecule Characterization of Amyloid Oligomers

  2021cites this paper
• Mild magnetic nanoparticle hyperthermia promotes the disaggregation and microglia-mediated clearance of Beta-amyloid plaques.

  2021cites this paper
• Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors.

  2021cites this paper
• New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease

  2020cites this paper
• Carnoquinolines Target Copper Dyshomeostasis, Aberrant Protein-Protein Interactions, and Oxidative Stress.

  2020cites this paper
• Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase

  2020cites this paper
• The English (H6R) Mutation of the Alzheimer’s Disease Amyloid-β Peptide Modulates Its Zinc-Induced Aggregation

  2020cites this paper
• N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study.

  2020cites this paper
• Silica Nanodepletors: Targeting and Clearing Alzheimer's β‐Amyloid Plaques

  2020cites this paper
• Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.

  2020cites this paper
• Resveratrol-mediated cleavage of amyloid β1-42 peptide: potential relevance to Alzheimer's disease.

  2020cites this paper
• Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity

  2020cites this paper
• Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation.

  2020cites this paper
• Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.

  2020cites this paper
• Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.

  2020cites this paper
• Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease

  2020cites this paper
• Photomodulating Carbon Dots for Spatiotemporal Suppression of Alzheimer's β-Amyloid Aggregation.

  2020cites this paper
• Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems.

  2020cites this paper
• Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.

  2020cites this paper
• Hyaluronan-carnosine conjugates inhibit Aβ aggregation and toxicity

  2020cites this paper
• 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.

  2020cites this paper
• Characterization techniques of protein and peptide nanofibers: Self-assembly kinetics

  2020cites this paper
• Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.

  2020cites this paper
• Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase

  2020cites this paper
• Advanced analytical methodologies in Alzheimer's disease drug discovery.

  2020cites this paper
• Design, synthesis and evaluation of phthalide alkyl tertiary amine derivatives as promising acetylcholinesterase inhibitors with high potency and selectivity against Alzheimer's disease.

  2020cites this paper
• Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers

  2020cites this paper
• Turning Donepezil into a Multi‐Target‐Directed Ligand through a Merging Strategy

  2020cites this paper
• Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.

  2020cites this paper
• Investigation of polysaccharide extracts from Iranian and French strains of Agaricus subrufescens against enzymes involved in Alzheimer’s disease

  2019cites this paper
• Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease

  2019cites this paper
• Influence of methionine–ruthenium complex on the fibril formation of human islet amyloid polypeptide

  2019cites this paper
• Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.

  2019cites this paper
• An AIE-active theranostic probe for light-up detection of Aβ aggregates and protection of neuronal cells.

  2019cites this paper
• New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer’s Disease

  2019cites this paper